A Novavax Covid-19 vaccine would be the first authorized in the U.S. with a traditional protein-based platform
Outside panel to recommend whether the shot should be authorized, after the agency found it effective but flagged a heart-safety concern
Since the start of the Covid-19 pandemic in 2020, the scientific understanding of its transmission and prevention has evolved. WSJ’s Daniela Hernandez explains what strategies have worked for stemming the spread of the virus and which are outdated in 2022. Illustration: Adele MorganVaccine experts advising the Food and Drug Administration are scrutinizing Novavax Inc.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: